This radioresistance-conferring together with the reported tumor growth-promoting and the yet speculative metastasis-facilitating roles of the channel proposes KCa3.1 as a new target during fractionated radiation therapy of breast cancer and the maintenance therapy thereafter. The gene discussed is KCNN4; the disease is neoplasm.